Purpose To review the current therapeutic options for the management of diabetic
retinopathy (DR) and diabetic macular edema (DME) and examine the evidence for …

Abstract Purpose of Review Diabetes mellitus is a global epidemic which is growing in
prevalence, and diabetic macular edema (DME) is a leading cause of visual impairment …

Purpose To evaluate diabetic retinopathy (DR) outcomes with ranibizumab (Lucentis,
Genentech, Inc., South San Francisco, CA) treatment in patients with DR and diabetic …

Diabetic retinopathy is one of the major complications of diabetes mellitus and a leading
cause of visual loss. Diabetic macular edema (DME) is an ocular manifestation of the …

Diabetic macular edema (DME) is the most common cause of vision loss in diabetic eyes,
and due to the rapid rise in the number of diabetic patients, the treatment burden has …

Purpose To determine the characteristics of diabetic macular edema (DME) patients
refractory to intravitreal bevacizumab (IVB) treatments and an additional dexamethasone …

Background Early-stage diabetic retinopathy (DR) is characterized by neurovascular
defects. In this study, we hypothesized that human adipose-derived stem cells (ASCs) …

Сахарный диабет 1 типа у взрослых – тема научной статьи по клинической медицине
читайте бесплатно текст научно-исследовательской работы в электронной …

Purpose To determine clear-cut distinctions between tractional and exudative intraretinal
cystoid spaces subtypes. Design Retrospective, multicenter, observational case series …

Diabetic macular edema (DME) is a common cause of moderate visual impairment among
people with diabetes. Due to the rising number of people with diabetes in India, the absolute …